Clicky

Aptevo Therapeutics Inc.(APVO)

Description: Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.


Keywords: Biotechnology Hematology

Home Page: www.aptevotherapeutics.com

APVO Technical Analysis

2401 4th Avenue
Seattle, WA 98121
United States
Phone: 206 838 0500


Officers

Name Title
Mr. Marvin L. White Pres, CEO & Director
Mr. Jeffrey G. Lamothe CA Exec. VP & CFO
Dr. Jane A. Gross Ph.D. Chief Scientific Officer
Ms. SoYoung Kwon J.D., LL.M. Sr. VP, Gen. Counsel, Corp. Affairs & HR
Dr. Fatih M. Uckun M.D., Ph.D. Chief Clinical Advisor & Consultant
Dr. Dirk Huebner M.D. Chief Medical Officer
Ms. Daphne L. Taylor Sr. VP of Fin.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 3.9448
Trailing PE: 1.9706
Price-to-Book MRQ: 0.8141
Price-to-Sales TTM: 1.6074
IPO Date: 2016-07-20
Fiscal Year End: December
Full Time Employees: 54
Back to stocks